The mechanisms underlying the protective effects of resveratrol on various cardiovascular and metabolic disorders have not been established; however, evidence suggests that the inhibition of the mammalian target of rapamycin (mTOR) signaling pathway could play a role [50, 51]. This evidence concerns the gene MTOR and metabolic disease.